Cooper Companies (NASDAQ:COO) Releases FY 2025 Earnings Guidance

Cooper Companies (NASDAQ:COO - Get Free Report) issued an update on its FY 2025 earnings guidance on Thursday morning. The company provided earnings per share guidance of 4.050-4.110 for the period, compared to the consensus earnings per share estimate of 3.990. The company issued revenue guidance of $4.1 billion-$4.1 billion, compared to the consensus revenue estimate of $4.1 billion.

Cooper Companies Price Performance

COO stock traded down $11.02 during mid-day trading on Friday, reaching $68.94. 8,291,770 shares of the company's stock were exchanged, compared to its average volume of 1,531,454. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. Cooper Companies has a 12-month low of $65.95 and a 12-month high of $112.38. The stock's 50 day moving average is $79.82 and its 200 day moving average is $88.37. The company has a market cap of $13.79 billion, a price-to-earnings ratio of 35.35, a price-to-earnings-growth ratio of 2.25 and a beta of 1.08.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its earnings results on Thursday, May 29th. The medical device company reported $0.96 EPS for the quarter, topping analysts' consensus estimates of $0.93 by $0.03. The business had revenue of $1 billion during the quarter, compared to analysts' expectations of $995.12 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The company's quarterly revenue was up 6.3% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.85 earnings per share. On average, research analysts expect that Cooper Companies will post 3.98 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on COO shares. JPMorgan Chase & Co. reaffirmed a "neutral" rating and set a $76.00 target price (down previously from $110.00) on shares of Cooper Companies in a report on Friday. Wall Street Zen raised shares of Cooper Companies from a "hold" rating to a "buy" rating in a research note on Friday. BNP Paribas upgraded shares of Cooper Companies to a "hold" rating in a research note on Thursday, March 13th. Needham & Company LLC restated a "hold" rating on shares of Cooper Companies in a research note on Thursday, May 22nd. Finally, Wells Fargo & Company lowered their price objective on Cooper Companies from $118.00 to $93.00 and set an "overweight" rating for the company in a research report on Friday. Four analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $100.38.

Hedge Funds Weigh In On Cooper Companies

A hedge fund recently raised its stake in Cooper Companies stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 48.9% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 22,407 shares of the medical device company's stock after purchasing an additional 7,363 shares during the quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.'s holdings in Cooper Companies were worth $1,890,000 at the end of the most recent quarter. 24.39% of the stock is currently owned by institutional investors and hedge funds.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.